Lantern Pharma Inc. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Lantern Pharma Inc. (LTRN) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $75.60 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-03-30
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $75.60M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $43.60M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $34.50M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $29.10M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic as first filed |
|---|---|---|
| 2025-12-31 | $75.60M 10-K · filed 2026-03-30 | |
| 2024-12-31 | $43.60M 10-K · filed 2026-03-30 | |
| 2023-12-31 | $34.50M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $29.10M 10-K · filed 2024-03-18 | |
| 2021-12-31 | $22.80M 10-K · filed 2023-03-20 | $22.80T 10-K · filed 2022-03-10 |
| 2020-12-31 | $11.50T 10-K · filed 2022-03-10 | $11.50M 10-K · filed 2021-03-10 |
| 2019-12-31 | $6.50M 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |